Negative regulation of cell motility and invasiveness has also been reported for SLFN5 in renal cell carcinoma (RCC), in which SLFN5 expression is positively correlated with survival benefit80. This evidence concerns the gene SLFN5 and hereditary clear cell renal cell carcinoma.